R&D: Are true drug breakthroughs a thing of the past?

Fierce Biotech June 2013 One of the most intense discussions at ASCO over the past few days has zeroed in on the FDA’s new “breakthrough” drug status. The agency is offering developers essentially an open door at the FDA to…